Cargando…
Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review
The ongoing coronavirus disease 2019 (COVID-19) pandemic has resulted in efforts to identify therapies to ameliorate adverse clinical outcomes. The recognition of the key role for increased inflammation in COVID-19 has led to a proliferation of clinical trials targeting inflammation. The purpose of...
Autores principales: | Campbell, Courtney M., Guha, Avirup, Haque, Tamanna, Neilan, Tomas G., Addison, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565788/ https://www.ncbi.nlm.nih.gov/pubmed/32932930 http://dx.doi.org/10.3390/jcm9092935 |
Ejemplares similares
-
Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies
por: Biersmith, Michael A., et al.
Publicado: (2020) -
Cardio‐Oncology in the Era of the COVID‐19 Pandemic and Beyond
por: Addison, Daniel, et al.
Publicado: (2020) -
Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
por: Agha, Mounzer E, et al.
Publicado: (2021) -
Perspectives for repurposing drugs for the coronavirus disease 2019
por: Cherian, Sarah S., et al.
Publicado: (2020) -
Drug repurposing against coronavirus disease 2019 (COVID-19): A review
por: Luo, Lianxiang, et al.
Publicado: (2021)